Drug Information

Drug General Information
Drug ID
D0TT4H
Former ID
DNCL003523
Drug Name
E6005
Drug Type
Small molecular drug
Indication Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] Phase 2 [523673]
Company
Eisai
Formula
C26H24N4O5
PubChem Compound ID
24864553
Target and Pathway
Target(s) PDE4 Target Info Inhibitor [532353]
References
Ref 523673ClinicalTrials.gov (NCT01461941) A Phase 2 Study of E6005 in Patients With Atopic Dermatitis. U.S. National Institutes of Health.
Ref 532353Antipruritic effect of the topical phosphodiesterase 4 inhibitor E6005 ameliorates skin lesions in a mouse atopic dermatitis model. J Pharmacol Exp Ther. 2013 Jul;346(1):105-12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.